Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer
Fiona Simpkins(University of Pennsylvania Health System), Ronny Drapkin(University of Pennsylvania)
Cited by 2
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461
Ovarian Cancer Pathogenesis: A Model in Evolution
|Journal of Oncology|2009|294